{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-013344","form_type":"8-K","ticker":"CAPR","cik":"0001133869","company_name":"CAPRICOR THERAPEUTICS, INC.","filed_at":"2024-10-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.759494+00:00","generated_at":"2026-05-30T13:35:56.510947+00:00","sec_items":["2.02","8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Capricor files BLA for deramiocel in DMD cardiomyopathy; reports ~$85M cash as of Sept 30","bullets":["BLA for deramiocel filed Oct 2024 seeking full approval for DMD cardiomyopathy; full submission by year-end 2024.","HOPE-2/OLE data vs natural history supports BLA; HOPE-3 Cohorts A+B combined as post-approval study, Cohort A unblinding paused.","StealthX SARS-CoV-2 vaccine selected for Project NextGen; manufacturing ongoing, delivery to NIAID by end-2024.","Private placement to Nippon Shinyaku: 2.8M shares at $5.36 for ~$15M; ATM sales: 5.5M shares at $9.84 avg for ~$53.9M.","Preliminary cash balance ~$85M as of Sept 30, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-013344","json":"https://secwatch.observer/filing/0001558370-24-013344.json","markdown":"https://secwatch.observer/filing/0001558370-24-013344.md","text":"https://secwatch.observer/filing/0001558370-24-013344.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133869/000155837024013344/0001558370-24-013344-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133869/000155837024013344/capr-20241016x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T13:35:56.510947+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}